MISSISSAUGA, ON, July 16 /CNW/ - Oryx Pharmaceuticals Inc. (Oryx) is
pleased to announce the introduction of prescription NAPRELAN(TM) tablets
(naproxen sodium tablets) for the management of the signs and symptoms of
osteoarthritis and rheumatoid arthritis.
